CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 52 filers reported holding CASI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $91,000 | +40.0% | 112,777 | +39.6% | 0.01% | 0.0% |
| Q4 2021 | $65,000 | +80.6% | 80,806 | +164.4% | 0.01% | +133.3% |
| Q3 2021 | $36,000 | -77.4% | 30,560 | -53.8% | 0.00% | -72.7% |
| Q1 2021 | $159,000 | +329.7% | 66,106 | +431.0% | 0.01% | +175.0% |
| Q4 2020 | $37,000 | -37.3% | 12,450 | -67.7% | 0.00% | -60.0% |
| Q3 2020 | $59,000 | +51.3% | 38,496 | +217.5% | 0.01% | +400.0% |
| Q4 2017 | $39,000 | -45.8% | 12,124 | -70.3% | 0.00% | -50.0% |
| Q3 2017 | $72,000 | – | 40,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |